Oncocyte to Present at the 23rd Annual Needham Virtual Growth Conference
Nachrichtenquelle: globenewswire
| 13.01.2021, 00:21 |
131
|
0
IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points
across the cancer care continuum, announced today that management is scheduled to present at the 23
rd Annual Needham Virtual Growth Conference.
Presentation details:
Following the conference, a webcast replay of the presentation will be available on the Investor section of the company’s website, www.oncocyte.com.
About Oncocyte Corporation
Oncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the cancer care continuum. The Company, through its proprietary tests